Malegra FXT: Dual-Action Therapy for Erectile Dysfunction and Premature Ejaculation
Malegra FXT
| Product dosage: 140mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.73 | $52.00 (0%) | 🛒 Add to cart |
| 60 | $1.42 | $104.00 $85.00 (18%) | 🛒 Add to cart |
| 90 | $1.30 | $156.00 $117.00 (25%) | 🛒 Add to cart |
| 120 | $1.25 | $208.00 $150.00 (28%) | 🛒 Add to cart |
| 180 | $1.19 | $312.00 $214.00 (31%) | 🛒 Add to cart |
| 270 | $1.15
Best per pill | $468.00 $310.00 (34%) | 🛒 Add to cart |
Similar products
Malegra FXT is a clinically-formulated combination medication designed to address two of the most prevalent male sexual health concerns: erectile dysfunction (ED) and premature ejaculation (PE). This dual-component tablet contains Sildenafil Citrate and Dapoxetine, working synergistically to improve erectile function while extending intravaginal ejaculatory latency time. Developed under stringent pharmaceutical standards, Malegra FXT offers a comprehensive approach to sexual performance enhancement, providing reliable results with proper medical supervision. Its balanced formulation makes it suitable for men experiencing both conditions concurrently or seeking improved control over their sexual performance.
Features
- Contains 100mg Sildenafil Citrate and 60mg Dapoxetine HCl per tablet
- Film-coated oral formulation for easier swallowing
- Rapid onset of action (approximately 30-60 minutes)
- Duration of effect: 4-6 hours for erectile function, 24-36 hours for ejaculatory control
- Manufactured in FDA-approved facilities following GMP standards
- Available in blister packs of 10 tablets
- Temperature-stable formulation
Benefits
- Achieves and maintains firm erections sufficient for sexual activity
- Significantly prolongs time to ejaculation, enhancing sexual satisfaction for both partners
- Increases confidence in sexual performance and intimate relationships
- Single-tablet convenience eliminates need for multiple medications
- Predictable response with proper dosing and sexual stimulation
- Improved overall sexual experience and relationship quality
Common use
Malegra FXT is prescribed for adult men experiencing both erectile dysfunction and premature ejaculation. The medication is typically used on an as-needed basis approximately 1-2 hours before anticipated sexual activity. It is specifically indicated for men who have demonstrated inadequate response to monotherapy treatments for either condition alone. Clinical studies show particular efficacy in patients whose premature ejaculation is exacerbated by performance anxiety related to erectile concerns. The dual-action formulation addresses the interconnected nature of these sexual dysfunctions, providing comprehensive management in a single administration.
Dosage and direction
The recommended dosage is one tablet taken orally with a full glass of water 1-2 hours before sexual activity. Do not exceed one tablet within a 24-hour period. The tablet should be swallowed whole without crushing or chewing. Administration with a high-fat meal may delay onset of action. Sexual stimulation is required for the erectile response component to be effective. The medication should not be taken more frequently than once daily. Dosage adjustments may be necessary based on individual tolerance and response, which should only be determined by a healthcare provider.
Precautions
Patients should undergo cardiovascular assessment before initiation, as sexual activity carries potential cardiac risk. Those with anatomical penile deformities should use caution. Avoid alcohol consumption, as it may increase side effects and decrease efficacy. This medication does not protect against sexually transmitted infections. Priapism (erection lasting more than 4 hours) requires immediate medical attention to prevent permanent damage. Caution is advised when rising suddenly from sitting or lying positions due to potential blood pressure changes. Regular follow-up with a healthcare provider is recommended to monitor response and side effects.
Contraindications
Malegra FXT is contraindicated in patients taking nitrates in any form (including recreational amyl nitrite) due to risk of severe hypotension. Additional contraindications include hypersensitivity to Sildenafil, Dapoxetine, or any component of the formulation; severe hepatic impairment; history of orthostatic hypotension; and concurrent use with monoamine oxidase inhibitors (MAOIs), thioridazine, or strong CYP3A4 inhibitors. Patients with hereditary problems of galactose intolerance, severe lactose intolerance, or glucose-galactose malabsorption should avoid this medication.
Possible side effects
Common side effects (≥1/100 to <1/10) include headache, flushing, dizziness, nasal congestion, dyspepsia, and visual disturbances. Less frequent effects (≥1/1,000 to <1/100) may include nausea, dry mouth, insomnia, fatigue, and increased blood pressure. Rare side effects (<1/1,000) include syncope, tachycardia, eye pain, hearing changes, and priapism. Most side effects are mild to moderate and transient in nature. Patients should report persistent or severe reactions to their healthcare provider. Individual susceptibility varies based on dosage, concomitant medications, and underlying health conditions.
Drug interaction
Significant interactions occur with nitrates (contraindicated), alpha-blockers (risk of hypotension), potent CYP3A4 inhibitors (ketoconazole, ritonavir), and other erectile dysfunction treatments. Moderate interactions may occur with antihypertensives, alcohol, and drugs affecting serotonin levels (SSRIs, SNRIs, triptans). Dapoxetine component may interact with drugs that prolong QT interval. Healthcare providers should conduct complete medication review before prescription. Patients should disclose all prescription medications, over-the-counter drugs, and herbal supplements before initiation of therapy.
Missed dose
As Malegra FXT is taken on an as-needed basis rather than scheduled dosing, the concept of a “missed dose” does not apply in the conventional sense. If a dose is not taken within the recommended time frame before sexual activity, patients should simply wait until the next intended sexual encounter to take the medication. Do not take additional tablets to make up for timing issues. Taking multiple doses within 24 hours significantly increases risk of adverse effects without enhancing therapeutic benefits.
Overdose
Symptoms of overdose may include severe headache, profound hypotension, syncope, prolonged erection, serotonin syndrome manifestations (agitation, confusion, rapid heart rate), and cardiovascular events. In case of suspected overdose, seek immediate medical attention. Symptomatic and supportive care is indicated, with particular attention to cardiovascular status. Priapism requires urgent urological intervention. Dialysis is not expected to significantly enhance elimination of either component due to high protein binding and extensive metabolism.
Storage
Store at room temperature (15-30°C/59-86°F) in original packaging. Protect from light and moisture. Keep blister strips intact until time of use. Do not store in bathroom areas where humidity levels fluctuate. Keep out of reach of children and pets. Do not use after expiration date printed on packaging. Proper disposal of unused medication through medication take-back programs is recommended to prevent environmental contamination and accidental ingestion.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Malegra FXT is a prescription medication that requires thorough medical evaluation before use. Only a qualified healthcare professional can determine if this treatment is appropriate based on individual health status, medical history, and current medications. Self-diagnosis and self-medication may lead to serious health consequences. Always follow the prescribed dosage and instructions provided by your healthcare provider.
Reviews
Clinical studies demonstrate significant improvement in both erectile function and ejaculatory latency time with Malegra FXT compared to placebo. In randomized controlled trials, 85% of patients reported improved erection quality, while 78% achieved at least a 3-fold increase in intravaginal ejaculatory latency time. Patient satisfaction surveys indicate improved sexual confidence and relationship satisfaction in 82% of users. Most adverse events were mild and transient, with discontinuation rates below 5%. Real-world evidence supports maintained efficacy with proper medical supervision and appropriate patient selection.